CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6898 result(s)

Insulin glulisine (Apidra)

Last Updated: August 29, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Insulin glulisine
Indications: Diabetes, Mellitus (Type 1 & 2)

  • Brand Name: Apidra
  • Manufacturer: Sanofi-Aventis Canada Inc.
  • Project Number: S0144
  • Project Status: Complete
  • Submission Type: New

Abatacept (Orencia)

Last Updated: August 29, 2008
Result type: Reports
Product Line: Common Drug Review
Generic Name: Abatacept
Indications: Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid

  • Brand Name: Orencia
  • Manufacturer: Bristol-Myers Squibb Canada
  • Project Number: S0145
  • Project Status: Complete
  • Submission Type: New Indication